Sandbox osteomyelitis: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
| Line 14: | Line 14: | ||
==Chronic Osteomyelitis in Adults – Pathogen-Based Therapy == | ==Chronic Osteomyelitis in Adults – Pathogen-Based Therapy == | ||
===Oxacillin-sensitive Staphylococcus aureus=== | ===Oxacillin-sensitive ''Staphylococcus aureus''=== | ||
{{rx|Preferred regimen}} | {{rx|Preferred regimen}} | ||
* Oxacillin 1.5-2 g IV q4h for 4-6 wk {{or}} Cefazolin 1-2 g IV q8h for 4-6 wk | * Oxacillin 1.5-2 g IV q4h for 4-6 wk {{or}} Cefazolin 1-2 g IV q8h for 4-6 wk | ||
Revision as of 18:02, 28 April 2015
Hematogenous Osteomyelitis
Acute Osteomyelitis in Adults
Acute Osteomyelitis in Children
Contiguous Osteomyelitis
Chronic Osteomyelitis in Adults – Pathogen-Based Therapy
Oxacillin-sensitive Staphylococcus aureus
- Oxacillin 1.5-2 g IV q4h for 4-6 wk OR Cefazolin 1-2 g IV q8h for 4-6 wk
- Vancomycin 15 mg/kg IV q12h for 4-6 wk
OR - Rifampin 600 mg PO qd AND oxacillin
Specific Considerations
Vertebral osteomyelitis
Osteomyelitis in patients with diabetes mellitus
Osteomyelitis in patients with vascular insufficiency
SAPHO syndrome
Chronic recurrent multifocal osteomyelitis
Osteitis Pubis
Osteomyelitis of the Clavicle
Osteomyelitis in Hemodialysis Patients
Osteomyelitis in Patients with Sickle Cell Disease Gaucher’s Disease
Osteomyelitis in Injection Drug Users
Skeletal Mycobacterial Infection
Fungal Osteomyelitis
Brodie’s Abscess
Culture-Negative Osteomyelitis